Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology. One of the key reasons lies in the disease's unique fibrotic ...
Zacks Small Cap Research on MSN
MTVA: New date for Vanoglipel (DA-1241) presented at AASLD…
MTVA READ THE FULL MTVA RESEARCH REPORT Business Update New Data from Phase 2a Trial of Vanoglipel (DA-1241) Presented at The Liver Meeting 2025 In November 2025, MetaVia, Inc. (NASDAQ:MTVA) announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback